Annual Working Capital
$27.70 M
-$18.02 M-39.41%
December 31, 2023
Summary
- As of February 8, 2025, ENLV annual working capital is $27.70 million, with the most recent change of -$18.02 million (-39.41%) on December 31, 2023.
- During the last 3 years, ENLV annual working capital has fallen by -$6.05 million (-17.91%).
- ENLV annual working capital is now -66.10% below its all-time high of $81.72 million, reached on December 31, 2021.
Performance
ENLV Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$24.32 M
-$1.41 M-5.48%
September 30, 2024
Summary
- As of February 8, 2025, ENLV quarterly working capital is $24.32 million, with the most recent change of -$1.41 million (-5.48%) on September 30, 2024.
- Over the past year, ENLV quarterly working capital has dropped by -$3.18 million (-11.57%).
- ENLV quarterly working capital is now -72.63% below its all-time high of $88.87 million, reached on March 31, 2021.
Performance
ENLV Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ENLV Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.4% | -11.6% |
| 3 y3 years | -17.9% | -24.3% |
| 5 y5 years | +202.9% | -24.3% |
ENLV Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.1% | at low | -70.2% | at low |
| 5 y | 5-year | -66.1% | +165.3% | -72.6% | +132.9% |
| alltime | all time | -66.1% | >+9999.0% | -72.6% | >+9999.0% |
Enlivex Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $24.32 M(-5.5%) |
| Jun 2024 | - | $25.73 M(+3.9%) |
| Mar 2024 | - | $24.77 M(-10.6%) |
| Dec 2023 | $27.70 M(-39.4%) | $27.70 M(+0.7%) |
| Sep 2023 | - | $27.50 M(+6.6%) |
| Jun 2023 | - | $25.79 M(-19.7%) |
| Mar 2023 | - | $32.13 M(-29.7%) |
| Dec 2022 | $45.72 M(-44.1%) | $45.72 M(-16.4%) |
| Sep 2022 | - | $54.70 M(-10.1%) |
| Jun 2022 | - | $60.84 M(-17.3%) |
| Mar 2022 | - | $73.56 M(-10.0%) |
| Dec 2021 | $81.72 M(+142.2%) | $81.72 M(-4.5%) |
| Sep 2021 | - | $85.55 M(-3.1%) |
| Jun 2021 | - | $88.25 M(-0.7%) |
| Mar 2021 | - | $88.87 M(+163.3%) |
| Dec 2020 | $33.75 M(+223.2%) | $33.75 M(+23.9%) |
| Sep 2020 | - | $27.23 M(-7.1%) |
| Jun 2020 | - | $29.32 M(-6.2%) |
| Mar 2020 | - | $31.27 M(+199.5%) |
| Dec 2019 | $10.44 M | $10.44 M(-22.8%) |
| Sep 2019 | - | $13.52 M(-6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $14.38 M(+9.9%) |
| Mar 2019 | - | $13.09 M(+43.1%) |
| Dec 2018 | $9.15 M(+189.3%) | $9.15 M(+486.3%) |
| Jun 2018 | - | $1.56 M(-50.7%) |
| Dec 2017 | $3.16 M(-63.3%) | $3.16 M(-15.6%) |
| Sep 2017 | - | $3.75 M(-20.7%) |
| Jun 2017 | - | $4.72 M(-23.6%) |
| Mar 2017 | - | $6.18 M(-28.2%) |
| Dec 2016 | $8.61 M(-51.8%) | $8.61 M(-23.6%) |
| Sep 2016 | - | $11.28 M(-26.5%) |
| Jun 2016 | - | $15.34 M(-23.9%) |
| Mar 2016 | - | $20.15 M(+12.7%) |
| Dec 2015 | $17.88 M(-41.6%) | $17.88 M(-18.9%) |
| Sep 2015 | - | $22.05 M(-12.1%) |
| Jun 2015 | - | $25.08 M(-10.5%) |
| Mar 2015 | - | $28.02 M(-8.4%) |
| Dec 2014 | $30.61 M(>+9900.0%) | $30.61 M(-8.2%) |
| Sep 2014 | - | $33.33 M(+807.7%) |
| Jun 2014 | - | $3.67 M(+2085.7%) |
| Dec 2013 | $168.00 K(+124.0%) | $168.00 K |
| Dec 2012 | $75.00 K | - |
FAQ
- What is Enlivex Therapeutics annual working capital?
- What is the all time high annual working capital for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual working capital year-on-year change?
- What is Enlivex Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly working capital year-on-year change?
What is Enlivex Therapeutics annual working capital?
The current annual working capital of ENLV is $27.70 M
What is the all time high annual working capital for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual working capital is $81.72 M
What is Enlivex Therapeutics annual working capital year-on-year change?
Over the past year, ENLV annual working capital has changed by -$18.02 M (-39.41%)
What is Enlivex Therapeutics quarterly working capital?
The current quarterly working capital of ENLV is $24.32 M
What is the all time high quarterly working capital for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly working capital is $88.87 M
What is Enlivex Therapeutics quarterly working capital year-on-year change?
Over the past year, ENLV quarterly working capital has changed by -$3.18 M (-11.57%)